Annemieke J. Wouterse
Director/Miembro de la Junta en Polyganics BV .
Cargos activos de Annemieke J. Wouterse
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
NV NOM
 NV NOM Investment ManagersFinance NV NOM (NV NOM) is a private equity firm founded in 1974. The firm is headquartered in Groningen, Netherlands. | Inversor de Capital Privado | 01/10/1999 | - |
Polyganics BV
 Polyganics BV Medical SpecialtiesHealth Technology Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands. | Director/Miembro de la Junta | 04/07/2012 | - |
Historial de carrera de Annemieke J. Wouterse
Antiguos cargos conocidos de Annemieke J. Wouterse.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Mucosis BV
 Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Director/Miembro de la Junta | 01/10/2010 | - |
Formación de Annemieke J. Wouterse.
| Erasmus University Rotterdam | Undergraduate Degree |
Estadísticas
Internacional
| Países Bajos | 5 |
Operativa
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
NV NOM
NV NOM Investment ManagersFinance NV NOM (NV NOM) is a private equity firm founded in 1974. The firm is headquartered in Groningen, Netherlands. | Finance |
Polyganics BV
Polyganics BV Medical SpecialtiesHealth Technology Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands. | Health Technology |
Mucosis BV
Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Commercial Services |
